Related Research Articles
Emil "Tom" Frei III was an American physician and oncologist. He was the former director and former physician-in-chief of the Dana–Farber Cancer Institute in Boston, Massachusetts. He was also the Richard and Susan Smith Distinguished Professor of Medicine at Harvard Medical School.
Susan Swedo is a researcher in the field of pediatrics and neuropsychiatry. Beginning in 1998, she was Chief of the Pediatrics & Developmental Neuroscience Branch at the US National Institute of Mental Health. In 1994, Swedo was lead author on a paper describing pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS), a controversial hypothesis proposing a link between Group A streptococcal infection in children and some rapid-onset cases of obsessive-compulsive disorder (OCD) or tic disorders such as Tourette syndrome. Swedo retired from the NIH in 2019, and serves on the PANDAS Physician Network.
Charles L. Sawyers is a Howard Hughes Medical Institute (HHMI) investigator who holds the Marie-Josée and Henry R. Kravis Chair of the Human Oncology and Pathogenesis Program (HOPP) at Memorial Sloan Kettering Cancer Center (MSK). HOPP is a program created in 2006 that comprises researchers from many disciplines to bridge clinical and laboratory discoveries.
John Mendelsohn was a president of the University of Texas MD Anderson Cancer Center in Houston. He was an internationally recognized leader in cancer research.
Clara Derber Bloomfield, was an American physician and cancer researcher. Her work focused on the genetic changes that are present in certain types of blood cancers, and how those can be utilized to improve treatment for the affected patients.
Alan D. D'Andrea is an American cancer researcher and the Fuller American Cancer Society Professor of Radiation Oncology at Harvard Medical School. D'Andrea's research at the Dana Farber Cancer Institute focuses on chromosome instability and cancer susceptibility. He is currently the director of the Center for DNA Damage and Repair and the director of the Susan F. Smith Center for Women's Cancer.
Waun Ki Hong was Professor of Medicine at The University of Texas MD Anderson Cancer Center, where he served as chairman of the Department of Thoracic/Head & Neck Medical Oncology from 1993 to 2005 and as head of the Division of Cancer Medicine from 2001 to 2014. He was also an American Cancer Society Professor and the Samsung Distinguished University Chair in Cancer Medicine emeritus.
William G. Kaelin Jr. is an American Nobel laureate physician-scientist. He is a professor of medicine at Harvard University and the Dana–Farber Cancer Institute. His laboratory studies tumor suppressor proteins. In 2016, Kaelin received the Albert Lasker Award for Basic Medical Research and the AACR Princess Takamatsu Award. He also won the Nobel Prize in Physiology or Medicine in 2019 along with Peter J. Ratcliffe and Gregg L. Semenza.
Michael A. Caligiuri, M.D. is a physician scientist focused on oncology and immunology. He is currently the president of the City of Hope National Medical Center and the Deana and Steve Campbell Physician-in-Chief Distinguished Chair. He was elected president of the American Association for Cancer Research, the world's largest cancer research organization, for 2017–2018. He was previously the CEO of the James Cancer Hospital (2008-2017), Director of the Comprehensive Cancer Center (2003-2017), and Director of the Division of Hematology-Oncology (2000-2008) at the Ohio State University. He was elected to the United States National Academy of Medicine in 2018.
Bruce Allan Chabner is a professor of medicine at Harvard Medical School and Director of Clinical Research at the MGH Cancer Center at Massachusetts General Hospital. His research focuses on anti-folate drugs for the treatment of cancer.
Elizabeth M. Jaffee is an American oncologist specializing in pancreatic cancer and immunotherapy.
Teresa J. Vietti was an American physician. She is best known for her pioneering work and research in pediatric cancer. Her research discovered the genetics of leukemia, new chemotherapy agents and tracked the effects of chemotherapy on childhood cancer survivors. Vietti also wrote about her research and was an editor of the Journal of Pediatric Hematology and a co-editor of Clinical Pediatric Oncology. According to Washington University in St. Louis, she was known as "the mother of pediatric cancer therapy."
Joseph Rocco Bertino was a researcher in the cancer pharmacology program at Rutgers Cancer Institute of New Jersey and professor of medicine and pharmacology at the Robert Wood Johnson Medical School in New Jersey. His research is focused on the treatment of lymphoma.
Judy Ellen Garber is the director of the Center for Cancer Genetics and Prevention at the Dana–Farber Cancer Institute and a professor of medicine at Harvard Medical School. Garber previously served as president of the American Association for Cancer Research.
Kornelia Polyak is a professor of medicine at Harvard Medical School and an internationally recognized breast cancer expert.
Crystal L. Mackall is an American physician and immunologist. She is currently the Ernest and Amelia Gallo Family Professor of Pediatrics and Medicine at Stanford University. She is the founding director of the Stanford Center for Cancer Cell Therapy.
Philip A. Pizzo is an American professor, physician, and scientist. He is the David and Susan Heckerman Professor of Microbiology and Immunology, Emeritus at Stanford University, and founding director of Stanford's Distinguished Careers Institute. He served as the 11th Dean of the Stanford University School of Medicine from 2001 to 2012. He spent over two decades at the National Institutes of Health, and has devoted much of his medical career to the diagnosis, management, prevention and treatment of children with cancer and AIDS. He has also focused on the future of higher education, specifically for individuals in mid- to late-life. In 2022, he enrolled as a rabbinical student at the Academy for Jewish Religion, California.
Jonathan Lester Finlay is a pediatric neuro-oncologist specializing in the management of children, adolescents and young adults with brain tumors. He is the director of Neuro-oncology at Nationwide Children's Hospital, where he also serves as the Elizabeth and Richard Germain Endowed Chair in Pediatric Cancer. He also is professor of pediatrics at The Ohio State University College of Medicine.
James R. Downing is an American pediatric oncologist and executive. He is the president and chief executive officer of St. Jude Children's Research Hospital.
John Matthew Maris is an American pediatric oncologist. He is the Giulio D’Angio Endowed Professor of Pediatrics at the Children's Hospital of Philadelphia (CHOP) and Full Professor at the Perelman School of Medicine at the University of Pennsylvania.
References
- 1 2 "Susan Cohn receives AACR-Joseph H. Burchenal Memorial Award for Outstanding Achievement in Clinical Cancer Research". www.uchicagomedicine.org. Retrieved 2019-12-22.
- 1 2 3 "Susan L. Cohn". University of Illinois College of Medicine. Retrieved October 1, 2019.
- ↑ "Susan L. Cohn, MD". University of Illinois College of Medicine. Retrieved October 1, 2019.
- ↑ "Walter Stadler replaces Susan Cohn as UChicago Dean for Clinical Research; Sonali Smith steps in as interim chief of hem/onc". The Cancer Letter . April 12, 2019. Retrieved October 1, 2019.
- ↑ "Susan Lerner Cohn, MD, FASCO". American Society of Clinical Oncology. Retrieved October 1, 2019.
- ↑ "AACR-Joseph H. Burchenal Memorial Award for Outstanding Achievement in Clinical Cancer Research". American Society of Clinical Oncology. Archived from the original on October 1, 2019. Retrieved October 1, 2019.
| General | |
|---|---|
| National libraries | |
| Scientific databases | |
| Other | |
   | This biographical article related to a physician in the United States is a stub. You can help Wikipedia by expanding it. |